Steve Scala
Stock Analyst at TD Cowen
(4.60)
# 945
Out of 5,099 analysts
406
Total ratings
63.8%
Success rate
11.2%
Average return
Main Sectors:
Stocks Rated by Steve Scala
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LITE Lumentum Holdings | Reiterated: Hold | $685 | $680.16 | +0.71% | 1 | Nov 3, 2026 | |
| LLY Eli Lilly and Company | Reiterated: Buy | $1,250 | $1,409.38 | -11.31% | 49 | Oct 1, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $280 | $286.00 | -2.10% | 43 | Sep 28, 2026 | |
| MRK Merck & Co. | Reiterated: Hold | $137 → $155 | $144.67 | +7.14% | 32 | Sep 22, 2026 | |
| NVS Novartis AG | Reiterated: Hold | $180 | $159.26 | +13.02% | 36 | Sep 8, 2026 | |
| LON: AZN AstraZeneca PLC | Reiterated: Buy | 17,909p | 13,760p | +30.15% | 9 | Aug 31, 2026 | |
| SNY Sanofi | Reiterated: Hold | $57 | $45.33 | +25.74% | 26 | Aug 31, 2026 | |
| ELAN Elanco Animal Health | Rated: Buy | $32 | $24.57 | +30.24% | 18 | Aug 25, 2026 | |
| ZTS Zoetis | Rated: Buy | $104 → $94 | $82.99 | +13.27% | 25 | Aug 25, 2026 | |
| PFE Pfizer | Reiterated: Hold | n/a | $30.00 | - | 44 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $70 | $48.70 | +43.74% | 30 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $300 | $266.17 | +12.71% | 1 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $67 | $59.18 | +13.21% | 27 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $8 | $9.68 | n/a | 4 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $64 → $54 | $61.71 | n/a | 29 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 → $15 | $13.85 | n/a | 4 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16.77 | $11.41 | n/a | 2 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $42 | $66.40 | n/a | 4 | Dec 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.18 | n/a | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.04 | n/a | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 96.59 → CHF 109.47 | CHF 131.50 | n/a | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $155 | $40.19 | n/a | 3 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | 2,250p → 1,790p | 1,828p | n/a | 2 | Nov 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | CHF 367.00 | CHF 391.00 | n/a | 3 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | €41.33 → €98.00 | €80.98 | n/a | 2 | Jul 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.88 | n/a | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €67.17 → €76.75 | €149.15 | n/a | 4 | Dec 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $209 | $461.26 | n/a | 2 | Oct 3, 2017 |
Lumentum Holdings
Nov 3, 2026
Reiterated: Hold
Price Target: $685
Current: $680.16
Upside: +0.71%
Eli Lilly and Company
Oct 1, 2026
Reiterated: Buy
Price Target: $1,250
Current: $1,409.38
Upside: -11.31%
AbbVie
Sep 28, 2026
Reiterated: Buy
Price Target: $280
Current: $286.00
Upside: -2.10%
Merck & Co.
Sep 22, 2026
Reiterated: Hold
Price Target: $137 → $155
Current: $144.67
Upside: +7.14%
Novartis AG
Sep 8, 2026
Reiterated: Hold
Price Target: $180
Current: $159.26
Upside: +13.02%
AstraZeneca PLC
Aug 31, 2026
Reiterated: Buy
Price Target: 17,909p
Current: 13,760p
Upside: +30.15%
Sanofi
Aug 31, 2026
Reiterated: Hold
Price Target: $57
Current: $45.33
Upside: +25.74%
Elanco Animal Health
Aug 25, 2026
Rated: Buy
Price Target: $32
Current: $24.57
Upside: +30.24%
Zoetis
Aug 25, 2026
Rated: Buy
Price Target: $104 → $94
Current: $82.99
Upside: +13.27%
Pfizer
Aug 11, 2026
Reiterated: Hold
Price Target: n/a
Current: $30.00
Upside: -
Aug 3, 2026
Reiterated: Hold
Price Target: $70
Current: $48.70
Upside: +43.74%
Jul 13, 2026
Reiterated: Buy
Price Target: $300
Current: $266.17
Upside: +12.71%
Apr 23, 2026
Reiterated: Hold
Price Target: $67
Current: $59.18
Upside: +13.21%
Aug 7, 2025
Reiterated: Hold
Price Target: $9 → $8
Current: $9.68
Upside: n/a
Jul 31, 2025
Reiterated: Hold
Price Target: $64 → $54
Current: $61.71
Upside: n/a
Apr 22, 2025
Reiterated: Hold
Price Target: $19 → $15
Current: $13.85
Upside: n/a
Feb 21, 2025
Reiterated: Hold
Price Target: $16.77
Current: $11.41
Upside: n/a
Dec 24, 2024
Rated: Buy
Price Target: $42
Current: $66.40
Upside: n/a
Nov 18, 2024
Downgraded: Hold
Price Target: n/a
Current: $4.18
Upside: n/a
Nov 18, 2024
Downgraded: Hold
Price Target: n/a
Current: $1.04
Upside: n/a
Nov 11, 2024
Reiterated: Hold
Price Target: CHF 96.59 → CHF 109.47
Current: CHF 131.50
Upside: n/a
Apr 30, 2024
Reiterated: Buy
Price Target: $80 → $155
Current: $40.19
Upside: n/a
Nov 30, 2023
Reiterated: Hold
Price Target: 2,250p → 1,790p
Current: 1,828p
Upside: n/a
Nov 14, 2022
Downgraded: Hold
Price Target: CHF 367.00
Current: CHF 391.00
Upside: n/a
Jul 21, 2021
Initiated Coverage: Hold
Price Target: €41.33 → €98.00
Current: €80.98
Upside: n/a
Jun 24, 2021
Reiterated: Buy
Price Target: n/a
Current: $3.88
Upside: n/a
Dec 10, 2018
Reiterated: Hold
Price Target: €67.17 → €76.75
Current: €149.15
Upside: n/a
Oct 3, 2017
Reiterated: Buy
Price Target: $209
Current: $461.26
Upside: n/a